Abstract
Some non-motor features (e.g. dementia) present more frequently in glucocerebrosidase-associated Parkinson's Disease (GBA-PD). What is the autonomic profile in GBA-PD compared to PD non-carriers (iPD)? Is there any difference between carriers of severe (GBA-SM) vs. mild (GBA-MM) mutations?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
